Top

International Orthopaedics

Published in:

01-04-2012 | Original Paper

Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty

Authors: Melita Buljan, Damir Nemet, Branka Golubic-Cepulic, Goran Bicanic, Branko Tripkovic, Domagoj Delimar

Published in: International Orthopaedics | Issue 4/2012

Abstract

Purpose

Our aim was to evaluate the effectiveness of two different dosing regimens of human recombinant erythropoietin (rHu-EPO) for preoperative autologous blood collection in patients undergoing total hip arthroplasty (THA).

Methods

Prospective randomised trials in which erythropoietin 15,000 IU was administered intravenously twice a week or 30,000 IU once a week (total 90,000 IU) combined with ferrous II sulphate (Ferro-Gradumet 2) orally and compared with Ferro-Gradumet 2 alone.

Results

Although different dosing regimens of rHu-EPO administration during preoperative autologous blood donation have similar effects on the collection of two units of autologous blood, preoperative haemoglobin level and perioperative allogenic blood transfusion, a once weekly dose regimen of rHu-EPO was more convenient (although not statistically significantly) for patients.

Conclusion

We recommend the more practical and comfortable but yet highly effective therapeutic regimen with a single weekly intravenous administration of rHu-EPO for patients scheduled for THA.

Mercuriali F, Biffi E, Inghilleri G, Vinci A (1989) Low hematocrit: limiting factor in autologous blood predonation program. In: Genetet B, Habibi B (eds) Castelli D. Transfusion in Europe Paris ISBT, Paris

Young SW, Marsh DJ, Akhavani MA, Walker CG, Skinner JA (2008) Attitudes to blood transfusion post arthroplasty surgery in the United Kingdom: a national survey. Int Orthop 32(3):325–329. doi:10.1007/s00264-007-0330-0 PubMedCrossRef

Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A, Colotti MT (1993) Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 33(1):55–60PubMedCrossRef

Colomina MJ, Bago J, Pellise F, Godet C, Villanueva C (2004) Preoperative erythropoietin in spine surgery. Eur Spine J 13(Suppl 1):S40–S49. doi:10.1007/s00586-004-0754-9 PubMedCrossRef

Cheung WK, Goon BL, Guilfoyle MC, Wacholtz MC (1998) Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. Clin Pharmacol Ther 64(4):412–423. doi:10.1016/S0009-9236(98)90072-8 PubMedCrossRef

Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG, Kleinman JG, Vaamonde CA (1998) Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients. N Engl J Med 339(9):578–583. doi:10.1056/NEJM199808273390902 PubMedCrossRef

Peces R, de la Torre M, Alcazar R, Urra JM (1996) Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. N Engl J Med 335(7):523–524. doi:10.1056/NEJM199608153350717 PubMedCrossRef

Eckardt KU, Casadevall N (2003) Pure red-cell aplasia due to anti-erythropoietin antibodies. Nephrol Dial Transplant 18(5):865–869PubMedCrossRef

Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P (2002) Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346(7):469–475. doi:10.1056/NEJMoa011931346/7/469 PubMedCrossRef

10.

Co E (1997) Guide to the preparation, use and quality assurance of blood components, 3rd edn. Council of Europe Press, Strassbourg

11.

Green WS, Toy P, Bozic KJ (2010) Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. J Arthroplast 25(1):93–96. doi:10.1016/j.arth.2008.10.005 CrossRef

12.

Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL (2003) Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 43(4):459–469PubMedCrossRef

13.

Laupacis A, Feagan B, Wong C (1993) Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. COPES Study Group. Lancet 342(8867):378PubMedCrossRef

14.

Faris PM, Ritter MA, Abels RI (1996) The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 78(1):62–72PubMed

15.

Goldberg MA, McCutchen JW, Jove M, Di Cesare P, Friedman RJ, Poss R, Guilfoyle M, Frei D, Young D (1996) A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop (Belle Mead NJ) 25(8):544–552

16.

Cody J, Daly C, Campbell M, Donaldson C, Khan I, Vale L, Wallace S, Macleod A (2005) Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients. Cochrane Database Syst Rev (3):CD003895. doi:10.1002/14651858.CD003895.pub2

17.

Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A (2003) Recombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgery. Acta Anaesthesiol Scand 47(6):687–692PubMedCrossRef

18.

Perez-Ruixo JJ, Krzyzanski W, Hing J (2008) Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects. Clin Pharmacokinet 47(6):399–415PubMedCrossRef

19.

Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ (2004) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clin Pharmacol 44(9):991–1002. doi:10.1177/0091270004268411

20.

Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C (2002) Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am 84-A(2):216–220PubMed

21.

Prasad N, Padmanabhan V, Mullaji A (2007) Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop 31(1):39–44. doi:10.1007/s00264-006-0096-9 PubMedCrossRef

22.

Cheung W, Minton N, Gunawardena K (2001) Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly. Eur J Clin Pharmacol 57(5):411–418PubMedCrossRef

23.

Goodnough LT, Monk TG, Andriole GL (1997) Erythropoietin therapy. N Engl J Med 336(13):933–938. doi:10.1056/NEJM199703273361307 PubMedCrossRef

24.

Woo S, Jusko WJ (2007) Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin. Drug Metab Dispos 35(9):1672–1678. doi:10.1124/dmd.107.015248 PubMedCrossRef

25.

Rossert J, Casadevall N, Eckardt KU (2004) Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol 15(2):398–406PubMedCrossRef

26.

Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N (2004) Pure red-cell aplasia and epoetin therapy. N Engl J Med 351(14):1403–1408. doi:10.1056/NEJMoa040528351/14/1403 PubMedCrossRef

27.

Lee JH, Yoon KS, Park JS, Kang SB, Do SH, Kim JY (1999) Recombinant human erythropoietin using preoperative autologous donation in lumbar stenosis operations. J Korean Soc Spine Surg 6(3):5

28.

Goodnough LT, Skikne B, Brugnara C (2000) Erythropoietin, iron, and erythropoiesis. Blood 96(3):823–833PubMed

Title: Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty
Authors: Melita Buljan
Damir Nemet
Branka Golubic-Cepulic
Goran Bicanic
Branko Tripkovic
Domagoj Delimar
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: International Orthopaedics / Issue 4/2012
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-011-1367-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2012

Two-stage procedure protocol for minimally invasive plate osteosynthesis technique in the treatment of the complex pilon fracture

Tunnel position and graft orientation in failed anterior cruciate ligament reconstruction: a clinical and imaging analysis

Medium-term results after total clavicle resection in cases of osteitis: a consecutive case series of five patients

A comparative study of Colles’ fractures in patients between fifty and seventy years of age: percutaneous K-wiring versus volar locking plating

Comparative study of tibial posterior slope angle following cruciate-retaining total knee arthroplasty using one of three implants

Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacement